Solara Active Pharma Sciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Individual Investor
Equibles does not estimate personal net worth.
Ketan R. Cheda is recorded as Analyst at Individual Investor. Ketan R. Cheda has spoken on 2 earnings calls across 2 companies, most recently for Solara Active Pharma Sciences Limited on May 15, 2026. Those appearances were for Solara Active Pharma Sciences Limited and Fairchem Organics Limited. The companies whose calls Ketan R. Cheda spoke on are classified in the Healthcare and Basic Materials sectors.
“Team, I'd like to ask, since the WISAC facility is northward, so I'm assuming that we are not generating any revenues from there, but at the same time, is there any expenses that we are incurring on that facility LAPS?”
“Sir, can you tell us in FY26, what was the concentration in terms of the industry where we supplied our products, like paints being the highest, and what was the next highest industry, and so and so forth, at least top two, three?”
Individual Investor
Analyst
Transcript header (unverified)
Solara Active Pharma Sciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Fairchem Organics Limited
Specialty Chemicals · Basic Materials
Earnings Call for the Quarter Ended March 31, 2026
Solara Active Pharma Sciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Fairchem Organics Limited